Weekly Roundup – 6/23/06

J0262312_1 I’m afraid the herd is quite thinned this week.  In my mind, the big news of the week was from the Hill – the Kennedy/Enzi legislation which I posted about yesterday.  There was not a lot going on at the FDA. 

  • Families USA Study on Drug Prices and Medicare Part D – A study released this week by Families USA states that drug prices have risen since the advent of Medicare Part D.  This serves as a double blow – one to the image of the industry at a time when reform movements are afoot and – two to the beleaguered image of the prescription drug benefit for seniors, on which the jury is still out, but which has also had a rocky start.
  • FDA Issues Guide on Allergens in the Food Supply – While this doesn’t sound particularly headline grabbing, it is an interesting topic.  Judge for yourself if it does the job by clicking here.
  • FDA Still Doesn’t Post Janet Woodcock’s Testimony – For all the talk of promoting transparency, the agency still has not posted this testimony.  Looks like those of us who are interested are going to have to file a FOIA to get it.  I will be doing so this week and will keep you posted on the progress.

Have a good weekend everyone!

Share this:
Share this page via Email Share this page via Stumble Upon Share this page via Digg this Share this page via Facebook Share this page via Twitter
This entry was posted in Weekly Roundup. Bookmark the permalink.

Comments are closed.